INTRODUCTION
The genus Ralstonia, established in 1995, includes 13 species of Gram-negative, non-fermentative bacilli (Yabuuchi et al., 1995) . Ralstonia species grow well in moist environments with minimal nutrient resources. The species most frequently encountered in human medicine is Ralstonia pickettii (formerly Pseudomonas pickettii and Burkholderia pickettii), which is most commonly isolated from the respiratory tract. Outbreaks of respiratory colonization have been described in association with contaminated solutions for patient care, but the presence of the pathogen in the respiratory tract is usually of no clinical significance (Labarca et al., 1999; Yoneyama et al., 2000) . Pseudo-outbreaks, due to contaminated laboratory solutions, have been described (Boutros et al., 2002) . In addition, Ralstonia paucula and Ralstonia gilardii may be associated with human disease (Moissenet et al., 2001; Vandamme et al., 1999; Wauters et al., 2001) . The recently established species Ralstonia mannitolilytica (previously named Pseudomonas thomasii and R. pickettii biovar 3/ 'thomasii') has been isolated from the respiratory tract of patients with cystic fibrosis, and was identified as the causative agent of recurrent meningitis and infection of a haematoperitoneum (Coenye et al., 2002a; De Baere et al., 2001; Vaneechoutte et al., 2001) . We observed an increase in cases of R. mannitolilytica infection in our hospital in 2002.
Biochemical identification of Ralstonia species with commercially available tests is problematic. R. pickettii is easily confounded with Burkholderia cepacia and Pseudomonas fluorescens (Henry et al., 2001; Kiska et al., 1996) . R. mannitolilytica shows similar biochemical properties to R. pickettii, but nitrate reduction (negative in R. mannitolilytica) and acidification of D-arabitol and mannitol (both negative in R. pickettii) have been reported to enable differentiation . In addition, it has been described that R. mannitolilytica strains are resistant to desferrioxamine, whereas R. pickettii strains are susceptible to this compound (Laffineur et al., 2002) . R. pickettii has been shown to grow on Burkholderia cepacia selective agar (BCSA) prepared according to Henry et al. (1997 Henry et al. ( , 1999 , but this has not been reported for other Ralstonia species. To date Abbreviations: OF, oxidation-fermentation; PFGE, pulsed-field gel electrophoresis; RAPD, random amplification of polymorphic DNA.
commercially available biochemical kits have rarely been updated in order to differentiate between R. mannitolilytica and R. pickettii. Recently, a PCR assay for identification of R. mannitolilytica targeting the 16S rRNA gene has been described (Coenye et al., 2002b) . This assay was shown to provide a sensitivity of 100 % and a specificity of 99 % (based on the examination of 34 R. mannitolilytica isolates and 118 control isolates). Random amplification of polymorphic DNA (RAPD) typing has previously been performed for R. mannitolilytica isolates using a primer set described for typing B. cepacia (Coenye et al., 2002b; Chen et al., 2001) . Additional studies have applied this technique for typing R. pickettii (Boutros et al., 2002; Maroye et al., 2000) . In the current work the R. pickettii RAPD primers P3 and P15 were employed for RAPD genotyping of 30 R. mannitolilytica clinical isolates.
The aims of this study were to characterize the strains using RAPD typing, to investigate the diagnostic accuracy of genotypic and phenotypic tests for species identification, and to determine the in vitro antimicrobial susceptibility pattern.
METHODS
Patients and isolates. R. mannitolilytica isolates from 26 patients of Vienna University Hospital (a 2200 bed University teaching hospital), isolated between February 2002 and March 2004, were included in this study [female, n ¼ 18; male, n ¼ 8; median age, 60 years (range, 42 to 85 years)]. Twenty-five patients were diagnosed with bacteraemia; if subsequent isolations of the same species were encountered within a 4 week period this was considered the same episode of bacteraemia, unless bacteraemia was diagnosed after readmission. Of the 26 patients studied, four experienced two episodes of bloodstream infection. The study isolates from patients with bloodstream infection were derived from peripheral blood (n ¼ 17), central blood (n ¼ 3), port-a-cath blood (n ¼ 7) and intravascular catheter tips (n ¼ 2). One patient was diagnosed with urinary tract infection. In this patient semi-quantitative urine culture yielded a count of 10 7 c.f.u. ml À1 . (Coenye et al., 2002b) . In addition, 16S rRNA gene sequencing for species identification was applied to seven of the R. mannitolilytica study isolates (MicroSeq 500 16S rDNA Bacterial Sequencing Kit; Applied Biosystems). Both the BLAST database (National Centre for Biotechnology Information, USA) and the MicroSeq database provided by Applied Biosystems were used to identify similarities between these sequences and known sequences.
PCR for identification of R. mannitolilytica. PCR was regarded as the gold standard for identification of the pathogen at species level. One isolate from each episode (n ¼ 30) was included in the present study. DNA from pure culture was extracted by the Qiamp DNeasy kit (Qiagen) according to the manufacturer's recommendations. PCR was performed as described previously using the primers Rm-F1 (59-GGG AAA GCT TGC TTT CCT GCC-39) and Rm-R1 (59-TCC GGG TAT TAA CCA GAG CCA T-39) (Coenye et al., 2002b) . The PCR mixture included a Ready-To-Go (RTG) PCR bead (Amersham Biosciences), 2 ìl (50 pmol) of each primer (VBC genomics), 3 ìl of DNA solution and sterile distilled water to a final volume of 25 ìl. The amplification conditions included an initial denaturation (94 8C for 2 min), 30 cycles (94 8C for 1 min, 57 8C for 1 min, 72 8C for 90 s) and a final extension (72 8C for 10 min). The PCR products were analysed by electrophoresis in a 2 % agarose gel (Agarose MP, Roche Diagnostics) for 1 . 5 h (5 V cm À1 ) and ethidium bromide staining. In-house sequenced strains of R. pickettii and Pseudomonas huttiensis (MicroSeq 500 16S rDNA Bacterial Sequencing Kit) were used as negative controls.
Comparison of commercially available identification systems.
Three different commercially available identification systems were applied to the 30 isolates: API 20NE, VITEK GNI+ and VITEK GNB. The assays were performed according to the manufacturer's recommendations.
Key reactions for differentiation of R. mannitolilytica from R. pickettii. Three biochemical reactions that have been shown to discriminate between R. mannitolilytica (negative for nitrate reduction) and R. pickettii (negative for acidification of D-arabitol and mannitol) were investigated . Acidification of D-arabitol and mannitol were determined by oxidation-fermentation (OF)-tests (basic medium: Merck). Nitrate reduction was investigated by cultivation of the isolates in nitrate reduction broth (Fluka) and addition of NIT 1 (sulfanilic acid, acetic acid) and NIT 2 (N,N-dimethyl-1-naphthylamine) after 48 h of incubation at 35 8C. In addition, a commercially available test for nitrate reduction (Nitrati Test, Liofilchem) was applied. Susceptibility to desferrioxamine was determined using 6 mm (diameter) paper discs loaded with 250 ìg of desferrioxamine. An in-house sequenced strain of R. pickettii, and Staphylococcus epidermidis DSM 20044 (organisms which have been reported to be susceptible to desferrioxamine), as well as Klebsiella oxytoca ATCC 700324 (Klebsiella species are not inhibited by desferrioxamine) were used as control organisms (Laffineur et al., 2002; Lindsay & Riley, 1991) .
In vitro susceptibility testing. In vitro susceptibility testing was performed by Kirby-Bauer disc diffusion test on Mueller-Hinton agar according to NCCLS guidelines. The following compounds were tested (required diameters for resistance, intermediate susceptibility, and susceptibility are given in parentheses): piperacillin-tazobactam (<17, 18-20, >21), ceftazidime (<14, 15-17, >18), cefepime (<14, 15-17, >18), imipenem (<13, 14-15, >16), gentamicin (<12, 13-14, >15), amikacin (<14, 15-16, >17) and ciprofloxacin (<15, 16-20, >21).
Growth on Burkholderia cepacia selective agar (BCSA). BCSA plates were prepared as described by Henry et al. (1997) . Strains from overnight cultures on MacConkey agar were subcultured on BCSA. The presence or absence of bacterial growth, and the colours of colonies and haloes, were documented after 24 and 48 h of incubation at 35 8C. In addition to R. mannitolilytica, isolates of Stenotrophomonas maltophilia (n ¼ 91), R. pickettii (n ¼ 26) and Alcaligenes (Achromobacter) xylosoxidans (n ¼ 19) were investigated; species identification of the R. pickettii
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isolates was performed by PCR as described by Coenye et al. (2002b) . Four B. cepacia isolates were used as positive controls.
Random amplification of polymorphic DNA (RAPD). A previously described RAPD primer set (P3: 59-AGA CGT CCA C-39, and P15: 59-AAT GGC GCA G-39) was applied (Maroye et al., 2000) . DNA from pure culture was extracted by the Qiamp DNeasy kit (Qiagen) according to the manufacturer's recommendations. The PCR mixture included a Ready-To-Go (RTG) RAPD Analysis bead (Amersham Biosciences), 2 ìl (50 pmol) of one of the primers (VBC Genomics), 3 ìl of DNA solution and sterile distilled water to a final volume of 25 ìl. The amplification conditions included an initial denaturation (94 8C for 5 min), 40 cycles (94 8C for 30 s, 36 8C for 30 s, 72 8C for 90 s). PCR was performed in a TGradient thermocycler (Biometra). RAPD products were analysed by electrophoresis in 2 % NuSieve 3 : 1 agarose gel (Cambrex) for 2 . 5 h (2 . 5 V cm À1 ) and ethidium bromide staining. The patterns were interpreted visually by two researchers; single-band differences were ignored (Renders et al., 1996) .
RESULTS
RAPD using the primer P3 revealed four clusters of isolates with different genotypes. RAPD using primer P15 yielded corresponding results (Fig. 1 ). According to RAPD using P3/ P15, most isolates belonged to two major clusters, A/I and B/ II, which consisted of 15 and 13 isolates, respectively, while two strains had distinct genotypes and individually formed C/III and D/IV. The genotype of each of the 30 isolates is indicated in Table 1 .
Comparison of commercially available identification systems and biochemical reactions
Four, 11 and 11 isolates were negative or yielded no acceptable biochemical profile using API 20NE, VITEK GNI+ and VITEK GNB, respectively. Fourteen, 16 and 15 isolates, respectively, were identified as R. pickettii using the same systems. The most frequent misidentification of R. mannitolilytica by the VITEK programs was as B. cepacia (two isolates each), while API 20NE classified 11 isolates (37 %) as Pseudomonas fluorescens. The detailed results of these tests for the 30 isolates are shown in Table 1 .
None of the isolates acidified D-arabitol or mannitol. Two isolates (7 %) were positive for nitrate reduction ( Table 1 ). All of the R. mannitolilytica isolates and K. oxytoca ATCC 700324 were resistant to desferrioxamine (no inhibition zone). The in-house sequenced R. pickettii strain and S. epidermidis DSM 20044 showed inhibition diameters of 25 and 28 mm, respectively.
Growth on Burkholderia cepacia selective agar (BCSA)
All of the R. mannitolilytica isolates except one (genotype D/ IV) grew on BCSA agar (97 %), showing transparent colonies with red haloes after 24 h, and blue colonies with red haloes after 48 h of incubation at 35 8C. All the B. cepacia and R. pickettii isolates grew on BCSA, but only one of the 91 S. maltophilia isolates (1 %) and none of the A. xylosoxidans isolates did.
In vitro susceptibility testing
The genotype D/IV isolate was sensitive to all seven antimicrobial agents tested. All the R. mannitolilytica isolates of genotypes A/I, B/II and C/III were resistant to gentamicin and amikacin, and the genotype C/III isolate was also resistant to ceftazidime. Six genotype A/I and three genotype B/II isolates were sensitive to ceftazidime (as was the genotype D isolate), whilst the remaining 19 isolates (Table 2) .
DISCUSSION
RAPD detected only four different genotypes among the 30 R. mannitolilytica isolates. However, RAPD was not resolved by pulsed-field gel electrophoresis (PFGE), which is still the gold standard in molecular typing. Therefore, the sensitivity Fig. 1 .
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Journal of Medical Microbiology 54 of RAPD for typing Ralstonia species may be questioned. Previously published findings indicate that RAPD using the primer set P3/P15 is equal to PFGE for small-scale epidemiological investigations, although it should be noted that the isolates in this previous study by Boutros et al. (2002) were closely related, which hindered the comparison of one method against the other. In general, RAPD is an adequate typing method for Gram-negative non-fermentative rods (Mahenthiralingam et al., 1996) . A large-scale study on the comparative accuracy of RAPD and PFGE for typing the emerging pathogens Ralstonia species is warranted.
Recently described clinical manifestations of R. mannitolilytica include respiratory colonization in cystic fibrosis patients, recurrent meningitis and infection of a haematoperitoneum (Coenye et al., 2002a; De Baere et al., 2001; Vaneechoutte et al., 2001) . Before the establishment of the species R. mannitolilytica in 2001, bacteraemia and bacteriuria due to P. thomasii had been reported (Phillips et al., 1972) . All patients with R. mannitolilytica bacteraemia in the present study had fever when the positive blood culture(s) were drawn. Two patients (7 % of episodes) died. One patient in the present study, who had undergone recent renal transplantation, was diagnosed with a urinary tract infection due to R. mannitolilytica.
Most previously described cases of Ralstonia species infections were outbreak-related. In 1972, a P. thomasii outbreak involving 25 patients (bacteraemia and bacteriuria) was traced to parenteral fluids prepared with contaminated deionized water (Phillips et al., 1972) . Pan et al. (1992) reported that from 24 patients, 39 isolates were recovered which were preliminarily identified as R. pickettii, of which 23 actually belonged to P. thomasii. This outbreak was traced to contaminated saline solution prepared by the hospital pharmacy. In the present situation, 24 episodes of infection with R. mannitolilytica within 7 months represented an unusually high incidence, which was confirmed by continued surveillance of the pathogen until March 2004. Although the patients were treated at different wards located all over the hospital area, a common source of infection (related to therapeutic or diagnostic measures performed in the hospital) was considered. As Ralstonia species are known to cause outbreaks related to contaminated solutions for patient care, the first step of outbreak investigation was a review of the intravenous-therapy regimens of the patients. However, no single solution was identified to have been administered to all infected patients, so intravenous-therapy was excluded as the common source of infection. Comprehensive environmental screening, including approximately 250 samples (e.g. distilled water, saline solution, Ringer lactate, heparin solution, solvents, soaps and surfaces), was performed, but no Ralstonia species were isolated. Due to the lack of a plausible source of infection, no infection control measures were implemented. The prolonged outbreak stopped in autumn 2002. There appear to be two possible explanations for this epidemiological constellation, taking into account the results of molecular typing: (i) an unidentified common source containing several strains of R. mannitolilytica, and (ii) two distinctive epidemiological events (each with an as-yetunidentified common source) related to the common genotypes (A/I and B/II), with genotype D/IV reflecting an isolated incident. Genotype C/III may similarly reflect an isolated incident or may represent bacterial succession (genotypic adaptation) of the initial infectious agent. An environmental source (distilled water) harbouring five distinct strains of R. pickettii has previously been described (Maroye et al., 2000) . A similar constellation may be suspected in the present case, at least with regard to genotypes A/I and B/II. For three of the four patients with recurrent bacteraemia, the same strain was isolated during both episodes of bacteraemia. In these cases colonization with the causative strain is biologically plausible.
A true epidemic is most plausible in the present situation, due to: (1) the patients were treated in 15 different wards, (2) the R. mannitolilytica isolates were recovered and processed on different days, and (3) in 12 of the 30 episodes of bacteraemia more than one blood culture was positive for R. mannitolilytica. In addition, four patients experienced two Study of clinical R. mannitolilytica isolates episodes of bacteraemia. Given that an average of 16 000 sets of blood culture bottles are processed per year in our hospital, it is very unlikely that a second blood culture set from the same patient became contaminated with R. mannitolilytica randomly.
Correct identification of Ralstonia species is important because misidentification can highly compromise infection control measures. In addition, misidentification of Ralstonia species as B. cepacia can have a tremendous impact on the life of cystic fibrosis patients (Saiman & Siegel, 2004) . As previously reported for R. pickettii, R. mannitolilytica was most frequently confounded with P. fluorescens and B. cepacia in the present study (Henry et al., 2001; Kiska et al., 1996) . It has to be noted that the three commercially available identification systems tested in this study were not updated to identify R. mannitolilytica. However, given that the biochemical profile of R. mannitolilytica is most similar to that of R. pickettii, VITEK GNI+ showed the best performance, followed by VITEK GNB. The PCR assay for identification of R. mannitolilytica described by Coenye et al. (2002b) is a valuable tool for the identification of this species.
With regard to the biochemical differentiation of R. mannitolilytica from R. pickettii, the present data indicate that nitrate reduction is variable in R. mannitolilytica, although most isolates appear to be negative for this reaction. Mannitol has been described to be both assimilated and acidified by R. mannitolilytica . None of the R. mannitolilytica isolates in this study acidified mannitol, as determined by OF test. In contrast, the reaction 'mannitol' contained in API 20NE was positive for all isolates. The OF test determines acid production from mannitol, whilst API 20NE investigates assimilation (i.e. growth by utilization) of the respective sugar.
In addition to Burkholderia species, growth on Burkholderia cepacia selective agar (BCSA) has essentially been described for Pseudomonas species, Flavobacterium indologenes, A. xylosoxidans and yeasts, but growth of these organisms was only observed in a minority of isolates (Henry et al., 1997 (Henry et al., , 1999 Wright et al., 2001) . Growth of R. pickettii on this medium has been described previously, but this has not previously been studied for R. mannitolilytica. Additional experiments, in the course of the present study, showed that R. pickettii is more sensitive to elevated concentrations of crystal violet (.0 . 2 g l À1 ) than is R. mannitolilytica, but higher concentrations of crystal violet also led to slower growth of the latter organism.
The results of in vitro susceptibility testing against commonly used antibiotics were variable within genotypes A/I and B/II. This may be due to secondary acquisition of resistance. As an alternative explanation, the disc diffusion test may be inadequate and poorly reproducible for testing Ralstonia species, as has been shown for other Gram-negative nonfermentative bacilli (Denton & Kerr, 1998) . Further studies, with a higher number of isolates and incorporating additional methods (such as agar dilution, broth microdilution or Etest) are required to determine valid in vitro resistance rates of the pathogen. However, previous observations that antibiotyping (at least by disc diffusion test) is helpful in the initial discrimination of outbreak-related isolates were not confirmed in the present study (Boutros et al., 2002; Maroye et al., 2000) .
